Press Releases

Date	Title
5/8/26	Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
5/4/26	Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results
4/25/26	Pulse Biosciences Presents Positive Outcomes in Late-Breaking Updated Data from nPulse™ Cardiac Catheter System at Heart Rhythm 2026
4/20/26	Pulse Biosciences’ nPulse™ Technology to be Featured at the Heart Rhythm Society 2026 Annual Meeting
4/17/26	Pulse Biosciences to Host Analyst Event on April 25, 2026
4/9/26	Pulse Biosciences Strengthens Executive Leadership Team
4/7/26	Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
4/2/26	Pulse Biosciences to Present at the 25th Annual Needham Virtual Healthcare Conference
3/17/26	Pulse Biosciences Announces Strategic Alignment to Accelerate Cardiac Catheter Program Following Exceptional Long-Term AFib Clinical Data
3/12/26	Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology

Keyword Search